Stock Information
| Listing Segment | Euronext Paris: Eurolist Next Economy |
|---|---|
| FTSE Classification |
Economical group: non cyclical consumer goods (40) Industrial sector: pharmaceuticals (48) Industry sub-sector: pharmaceuticals (480) |
| Euroclear France code | 7413 |
| Reuters code | NCOX.PA |
| Bloomberg code | COX.FP |
| NYSE Euronext | SBF120 |
| Analyst coverage: Search based in France | |
| Share price | Euronext |
| Share capital | € 14,593,101.60 |
| Number of outstanding shares | 72,965,507 |
| Number of voting rights as of April 30, 2013 |
72,965,507 |
|
Total number of voting rights calculated on the basis of all the shares to which voting rights are attached even if exercise thereof is suspended |
72,965,507 |
| Public (as of 31.12.2012) | 85.63% |
| Shareholder structure | |
| To its knowledge, as of 31 December 2012, Nicox' capital structure was: | |
| Public | 85.63% |
| Main shareholders |
FSI The Northern Trust Company |
| Founding managers | 1.89% |